Collectively, these results indicated that myeloid-specific RBP-J deficiency alleviated neuroinflammation and DA neurodegeneration, which might be attributed to the decreased number of infiltrated IMs and less activated microglia during PD progression. The gene discussed is RBPJ; the disease is Parkinson disease.